Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • GSK Q1 net down 63% at...

    GSK Q1 net down 63% at Rs 26 crore on GST transition

    Written by Ruby Khatun Khatun Published On 2017-07-27T09:20:44+05:30  |  Updated On 27 July 2017 9:20 AM IST
    GSK Q1 net down 63% at Rs 26 crore on GST transition

    New Delhi: GlaxoSmithKline Pharmaceuticals (GSK) on Tuesday reported 63.44 per cent decline in standalone net profit to Rs 26.42 crore for the first quarter ended June 30, mainly on account of trade destocking due to transition into GST.


    The company had posted a net profit of Rs 72.27 crore for the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.


    "Sales revenue of the pharmaceuticals business declined 14.2 per cent during the quarter ended June 30, 2017 as compared to the corresponding quarter of the previous year," GlaxoSmithKline said.


    Sales were adversely impacted by an estimated Rs 130 crore in the quarter as a consequence of trade destocking due to transition into GST, it added.


    Standalone total revenue from operations stood at Rs 607.09 crore for the quarter under consideration, as against Rs 705.33 crore for the corresponding period a year ago.

    declineFinancial resultsGlaxoSmithKlineGSKGSTnet profitSales revenueTotal revenuetransition
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok